SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-025706
Filing Date
2020-09-18
Accepted
2020-09-18 16:14:46
Documents
2
Period of Report
2020-09-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4053
2 EX-24 DOCUMENT attachment1.htm EX-24 4431
  Complete submission text file 0000899243-20-025706.txt   10031
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-514-7149
Summit Therapeutics Inc. (Issuer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address
Mahatme Ujwala (Reporting) CIK: 0001823894 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36866 | Film No.: 201184159